Head and Neck Tumor Control Probability: Radiation Dose-Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working Group.

International Journal of Radiation Oncology, Biology, Physics
John A VargoDwight E Heron

Abstract

Stereotactic body radiation therapy (SBRT) has emerged as a viable reirradiation strategy for locally recurrent previously-irradiated head and neck cancer. Doses in the literature have varied, which challenges clinical application of SBRT as well as clinical trial design. A working group was formed through the American Association of Physicists in Medicine to study tumor control probabilities for SBRT in head and neck cancer. We herein present a systematic review of the available literature addressing the dose/volume data for tumor control probability with SBRT in patients with locally recurrent previously-irradiated head and neck cancer. Dose-response models are generated that present tumor control probability as a function of dose. Data from more than 300 cases in 8 publications suggest that there is a dose-response relationship, with superior local control and possibly improved overall survival for doses of 35 to 45 Gy (in 5 fractions) compared with <30 Gy. Stereotactic body radiation therapy doses equivalent to 5-fraction doses of 40 to 50 Gy are suggested for retreatment.

References

Nov 1, 1983·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·H R WithersL J Peters
Apr 12, 2002·The Journal of Laryngology and Otology·A P CoatesworthK MacLennan
Aug 13, 2002·Physics in Medicine and Biology·Panayiotis MavroidisAnders Brahme
Nov 16, 2002·Physics in Medicine and Biology·Beong Choi, Joseph O Deasy
Apr 16, 2003·International Journal of Radiation Oncology, Biology, Physics·Daniel T T ChuaLucullus H T Leung
Jun 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stuart J WongYi Li
Sep 20, 2006·Technology in Cancer Research & Treatment·George VoynovJonas Johnson
Nov 27, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Sandro V PorcedduTanya Holt
Jan 2, 2009·International Journal of Radiation Oncology, Biology, Physics·Kwang-Won RohYeon-Sil Kim
Mar 31, 2009·International Journal of Radiation Oncology, Biology, Physics·Farzan SiddiquiSamuel Ryu
May 26, 2009·International Journal of Radiation Oncology, Biology, Physics·Dwight E HeronStephen Y Lai
Aug 3, 2010·International Journal of Radiation Oncology, Biology, Physics·Mustafa CengizFadil Akyol
May 3, 2011·International Journal of Radiation Oncology, Biology, Physics·Mark W McDonaldUNKNOWN Expert Panel on Radiation Oncology-Head and Neck Cancer
Jul 19, 2011·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Koji KawaguchiYoshiki Hamada
Mar 9, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Hiromitsu IwataYuta Shibamoto
Jul 4, 2012·The Lancet Oncology·Vincent GrégoireBrian O'Sullivan
Jan 22, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Kyle WangBarton F Branstetter
Nov 23, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Eric F LartigauAndrew Kramar
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
May 30, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Aysen DizmanYildiz Guney
Jun 25, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carole FakhryMaura Gillison
Jun 20, 2015·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Mathieu LeclercVincent Grégoire
Jun 16, 2016·International Journal of Radiation Oncology, Biology, Physics·Diane C LingDwight E Heron

❮ Previous
Next ❯

Citations

May 22, 2019·Medical Physics·Yijun DingBernard L Jones
Feb 1, 2021·International Journal of Radiation Oncology, Biology, Physics·Scott G SoltysStanley Benedict
Apr 18, 2021·International Journal of Radiation Oncology, Biology, Physics·Jimm GrimmEllen Yorke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.